A randomized controlled trial of low-dose recombinant human interferons α-2b nasal spray to prevent acute viral respiratory infections in military recruits

The military population has a high disease burden of acute viral respiratory infections in China. To assess the efficacy and safety of a low-dose recombinant human interferon α-2b (rIFNα-2b) nasal spray in preventing acute viral respiratory infections in military population, we performed this random...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, LuLu, Yu, Shouyi, Chen, Qing, Duan, Zhaojun, Zhou, Jie, Mao, Chen, Yu, Dexian, Zhu, Wenchang, Nie, Jun, Hou, Yunde
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2010
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115383/
https://www.ncbi.nlm.nih.gov/pubmed/20394720
http://dx.doi.org/10.1016/j.vaccine.2010.03.062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115383/
https://www.ncbi.nlm.nih.gov/pubmed/20394720
http://dx.doi.org/10.1016/j.vaccine.2010.03.062

Ejemplares similares